Increased levels of reactive oxygen species (ROS) such as superoxide anions and hydrogen peroxide have been reported in many cancer cells and they have been implicated in carcinogenesis and tumor progression. Antioxidant enzymes, such as Manganese Superoxide Dismutase (MnSOD or SOD2) and Glutathione Peroxidase-1 (GPx1), act coordinately to neutralize ROS. These enzymes are also thought to contribute to cancer cell resistance to conventional radio-chemo-therapies. Although some relationships have been reported between psychosocial factors and the regulation of antioxidant enzymes, little is known about these relationships in the context of cancer progression.
t r a c t
Increased levels of reactive oxygen species (ROS) such as superoxide anions and hydrogen peroxide have been reported in many cancer cells and they have been implicated in carcinogenesis and tumor progression. Antioxidant enzymes, such as Manganese Superoxide Dismutase (MnSOD or SOD2) and Glutathione Peroxidase-1 (GPx1), act coordinately to neutralize ROS. These enzymes are also thought to contribute to cancer cell resistance to conventional radio-chemo-therapies. Although some relationships have been reported between psychosocial factors and the regulation of antioxidant enzymes, little is known about these relationships in the context of cancer progression.
The current study investigated the levels of MnSOD and GPx1in confirmed serous, high-grade tumor tissue from 60 ovarian cancer patients, and explored the relationship between the activity of these enzymes, the levels of tumor norepinephrine (NE), and patient mood as determined via pre-operative questionnaires. MnSOD activity was positively related to depressed mood (p = 0.025) and tumor NE (p = 0.023). In contrast, GPx1 activity was inversely related to fatigue (p = 0.015) and tumor NE (p = 0.009), and was positively associated with vigor (p = 0.024). These findings suggest that psychological state and adrenergic signaling are linked with antioxidant enzyme activity in ovarian cancer and may have implications for patient treatments and outcomes.
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Introduction
Defects in cancer cell metabolism that lead to increased steady-state levels of reactive oxygen species (ROS; i.e., superoxide anion and hydrogen peroxide) have been implicated in carcinogenesis and cancer progression (Reuter et al., 2010; Zhou et al., 2014) Although normal fluctuations in steady-state levels of ROS produced by metabolism are hypothesized to be important in normal cellular signaling (Holmstrom and Finkel, 2014) and associated with normal growth and development (Zhou et al., 2014) , increased steady-state levels of ROS are believed to lead to cellular and organismic damage (Reuter et al., 2010) as well as genomic instability, uncontrolled growth, and the inability to properly differentiate that is characteristic of the malignant phenotype (Zhou et al., 2014) . Thus, high levels of ROS are believed to activate signaling pathways that contribute to tumor cell proliferation, chemoresistance, invasion, and metastasis (Mates et al., 2012; Reuter et al., 2010; Zhou et al., 2014) .
Antioxidant enzymes neutralize ROS. The antioxidant enzyme Manganese Superoxide Dismutase (MnSOD) is particularly important in the conversion of superoxide anions produced in mitochondria during mitochondrial respiration to hydrogen peroxide while glutathione peroxidase (GPx1) then converts hydrogen peroxide to water and oxygen in the cytoplasm (Brigelius-Flohe and
